Enovis (ENOV) Accumulated Depreciation & Amortization (2010 - 2025)
Enovis (ENOV) reported Accumulated Depreciation & Amortization of $1.3 billion for Q4 2025, up 44.87% year-over-year from $927.8 million in Q4 2024, and up 44.87% quarter-over-quarter from $927.8 million in Q4 2024.
Enovis (ENOV) Accumulated Depreciation & Amortization (2010 - 2025) Analysis & Trends
Enovis (ENOV) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $1.3 billion in Q4 2025.
- Accumulated Depreciation & Amortization for Q4 2025 came in at $1.3 billion, up 44.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 billion (up 44.87% YoY), and the FY2025 annual result was $1.3 billion, up 44.87% from the prior year.
- Accumulated Depreciation & Amortization grew to $1.3 billion in Q4 2025 per ENOV's latest filing, from $927.8 million in the prior quarter.
- Over five years, Accumulated Depreciation & Amortization peaked at $1.3 billion in Q4 2025 and troughed at $217.1 million in Q4 2023.
- A 5-year average of $594.3 million and a median of $262.9 million in 2021 frame the typical range for Accumulated Depreciation & Amortization.
- The sharpest annual moves came in 2022 and 2024: Accumulated Depreciation & Amortization slipped 16.43% in 2022, then jumped 327.36% in 2024.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $262.9 million in 2021, then declined by 16.43% to $219.7 million in 2022, then dropped by 1.18% to $217.1 million in 2023, then jumped by 327.36% to $927.8 million in 2024, then soared by 44.87% to $1.3 billion in 2025.
- Business Quant data shows ENOV's Accumulated Depreciation & Amortization at $1.3 billion in Q4 2025, $927.8 million in Q4 2024, and $217.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Enovis | 1.24 Bn | 1.21 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.34 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 927.83 Mn |
| Dec 31, 2024 | 927.83 Mn |
| Dec 31, 2023 | 217.11 Mn |
| Dec 31, 2023 | 217.11 Mn |
| Dec 31, 2022 | 219.71 Mn |
| Dec 31, 2022 | 219.71 Mn |
| Dec 31, 2021 | 262.92 Mn |
| Dec 31, 2021 | 262.92 Mn |
| Dec 31, 2020 | 246.23 Mn |
| Dec 31, 2020 | 246.23 Mn |
| Dec 31, 2019 | 236.03 Mn |
| Dec 31, 2019 | 236.03 Mn |
| Dec 31, 2018 | 141.88 Mn |
| Dec 31, 2018 | 141.88 Mn |
| Dec 31, 2017 | 132.20 Mn |
| Dec 31, 2017 | 132.20 Mn |
| Dec 31, 2016 | 137.18 Mn |
| Dec 31, 2016 | 137.18 Mn |